Biography:
Dr. Frostegard is a globally educated, board-certified physician holding MD summa cum laude. She obtained her PhD in Experimental Medicine at Karolinska Institutet, Stockholm, Sweden. Dr. Frostegard served as Assistant Professor at the Unit of Immunology and Chronic Disease at Karolinska Institutet. She has an active career in both science and business. She is the co-founder and currently the Chief Scientific and Medical Officer in Annexin Pharmaceuticals AB (publ). Dr. Frostegård has over 15 years of “first hand” entrepreneurial, executive, strategic and operational leadership in: Therapeutic Areas: inflammation & immunology, autoimmunity, cardiovascular, ophthalmology, infection, immuno-oncology.
Title : New therapeutic strategies in retinal vascular diseases: A lipid target phosphatidylserine and Annexin A5 a future theranostic pairing in ophthalmology